Kiora Pharmaceuticals, Inc. (KPRX) ownership: Top institutional holder: ADAR1 Capital Management, LLC ($324126.00). Insider activity: Net Seller (3 buys, 17 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 167941.00 | $324126.00 | 2026-03-31 |
| Stonepine Capital Management, LLC | 131144.00 | $258354.00 | 2025-12-31 |
| Nantahala Capital Management, LLC | 106156.00 | $209127.00 | 2025-12-31 |
| Alyeska Investment Group, L.P. | 76904.00 | $151501.00 | 2025-12-31 |
| CITADEL ADVISORS LLC | 49533.00 | $95599.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 47850.00 | $92349.00 | 2026-03-31 |
| VANGUARD GROUP INC | 33091.00 | $65189.00 | 2025-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 21200.00 | $41764.00 | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-07-01 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 |
Back to KPRX overview · KPRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.